IMUGENE LTD (IUGNF:OTCMKTS)
$0.085 0.0031 (3.7851%)
Analysed IMUGENE LTD (IUGNF:OTCMKTS) News Sources
Imugene valuation points to 129% upside as broker backs azer-cel strategy
13-05-2026
proactiveinvestors.com
Diamond Equity Research Releases Update Note on Imugene Limited (ASX: IMU)
20-05-2026
yahoo.com
Imugene flags strong early azer-cel responses ahead of ASCO spotlight
22-05-2026
proactiveinvestors.com
Imugene strengthens board with biotech and pharma appointments
26-05-2026
proactiveinvestors.com
Imugene doses first patient in BTKi combination cohort for azer-cel study
28-05-2026
proactiveinvestors.com
Imugene targets blood cancer with off-the-shelf CAR-T - ICYMI
29-05-2026
proactiveinvestors.com
Small Cap Watch: commercial expansion updates drive news flow
01-06-2026
proactiveinvestors.com
Imugene showcases Azer-Cel progress at ASCO - ICYMI
05-06-2026
proactiveinvestors.com
Inside Biotech: FDA fast-track nod sharpens focus on Imugene's off-the-shelf CAR T ambitions
09-06-2026
proactiveinvestors.com
FDA Fast Track opens new path for Imugene's Azer-cel - ICYMI
11-06-2026
proactiveinvestors.com
What is the current price of IMUGENE LTD (IUGNF:OTCMKTS)?
The current price of IMUGENE LTD (IUGNF:OTCMKTS) is $0.085.
IMUGENE LTD (IUGNF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of IMUGENE LTD (IUGNF:OTCMKTS) since the previous trading day is $0.0031.
IMUGENE LTD (IUGNF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of IMUGENE LTD (IUGNF:OTCMKTS) since the previous trading day is 3.7851%.
What is the most recent average sentiment score for IMUGENE LTD (IUGNF:OTCMKTS)?
The most recent average sentiment score for IMUGENE LTD (IUGNF:OTCMKTS) is 75 out of 100.
What is the most recent average sentiment for IMUGENE LTD (IUGNF:OTCMKTS)?
The most recent sentiment for IMUGENE LTD (IUGNF:OTCMKTS) is .
SEC-8K** Filing Available For IMUGENE LTD (IUGNF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.